Recent News

• 06.05.2025 - AFFINITY DUCHENNE® Trial of RGX-202
• 06.05.2025 - AFFINITY DUCHENNE® Trial of RGX-202
• 06.05.2025 - REGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
• 06.05.2025 - REGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
• 06.02.2025 - REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202
• 06.02.2025 - REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202
• 05.27.2025 - Stifel Virtual Ophthalmology Forum
• 05.27.2025 - Stifel Virtual Ophthalmology Forum
• 05.20.2025 - H.C. Wainwright BioConnect
• 05.20.2025 - H.C. Wainwright BioConnect

Recent Filings

• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 8-K Current report
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities